| LincRNA-immunity landscape analysis identifies EPIC1 as a regulator of tumor immune evasion and immunotherapy resistance W Guo, Y Wang, M Yang, Z Wang, Y Wang, S Chaurasia, Z Wu, M Zhang, ... Science Advances 7 (7), eabb3555, 2021 | 32 | 2021 |
| MYC‐binding lncRNA EPIC1 promotes AKT‐mTORC1 signaling and rapamycin resistance in breast and ovarian cancer Y Wang, M Zhang, Z Wang, W Guo, D Yang Molecular carcinogenesis 59 (10), 1188-1198, 2020 | 10 | 2020 |
| Genome-wide gain-of-function screening characterized lncRNA regulators for tumor immune response Y Wang, Y Zhao, W Guo, GS Yadav, C Bhaskarla, Z Wang, X Wang, S Li, ... Science Advances 8 (49), eadd0005, 2022 | 5 | 2022 |
| Systematic identification of the chemo-immunotherapy synergism to overcome immunotherapy resistance in cancer Y Wang, Y Wang, X Wang, Z Wang, M Zhang, D Yang Cancer Research 82 (12_Supplement), 5594-5594, 2022 | | 2022 |
